Natalie Reizine, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    EMD Serono
    Date added: 
    09/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Merck
    Date added: 
    09/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    AstraZeneca
    Date added: 
    09/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Tempus
    Date added: 
    09/25/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Sanofi
    Date added: 
    09/25/2023
    Relationship end date: 
    09/14/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Exelexis
    Date added: 
    09/25/2023
    Relationship end date: 
    12/22/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Janssen
    Date added: 
    09/25/2023
    Relationship end date: 
    07/03/2023
Return to Central Illinois Hematology Oncology Conference: Emphasis on Precision-Guided Management